Gromoslaw Aleksander Smolen

10PUBLICATIONS
107CO-AUTHORS
Tumour immunologyGene and molecular therapyPredictive and prognostic markersCancer cell biologyElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 20, 2026
LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer.

|Apr 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies.

Courtney D DiNardo, Amir T Fathi, Ashwin Kishtagari

|Nov 08, 2023
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma.

Igor Dolgalev, Hua Zhou, Nina Murrell

|Jul 28, 2023
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth.

Ali Rashidfarrokhi, Ray Pillai, Yuan Hao

|Aug 24, 2022
Author Correction: Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux.

Sanna N Masud, Megha Chandrashekhar, Michael Aregger

|Aug 15, 2022
Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux.

Sanna N Masud, Megha Chandrashekhar, Michael Aregger

Pageof 2

Frequent Collaborators

3 joint publications

Thales Papagiannakopoulos

3 joint publications

Aristotelis Tsirigos

3 joint publications

Michael Aregger

3 joint publications

Jason Moffat